XML 34 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note P - Stock Options
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE P
—STOCK OPTIONS
 
1999
Stock Option Plan
 
During
1999,
the Board of Directors of the Company adopted the
1999
Stock Option Plan (the
1999
Plan). The
1999
Plan was not presented to stockholders for approval and thus incentive stock options are not available under the plan. Under the
1999
Plan,
83,334
shares of common stock were reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices which
may
not be below
85%
of fair market value. The term of nonstatutory stock options granted
may
not exceed
ten
years. Options issued under the
1999
Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change in control, as defined, all options outstanding vest immediately. The
1999
Plan expired in
August
 
2009.
  
2004
Stock Option Plan
 
On
October
 
12,
2004,
the Board of Directors of the Company approved the
2004
Stock Option Plan (the
2004
Plan). The
2004
Plan was not presented to stockholders for approval and thus incentive stock options are not available under this plan. Under the terms of this plan,
166,667
shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices which
may
not be below
85%
of fair market value. The term of stock options granted
may
not exceed
ten
years. Options issued under the
2004
Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change in control, as defined, all options outstanding vest immediately. The
2004
Plan expired in
October
 
2014.
 
2015
Stock Option Plan
 
On
January
27,
2016,
the shareholders approved the
2015
Equity Incentive Plan (the
2015
Plan). Under the terms of this plan,
666,667
shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices which
may
not be below
100
-
110%
of fair market value. The term of stock options granted
may
not exceed
ten
years. Options issued under the
2015
Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change in control, certain stock awards issued under this plan
may
be subject to additional acceleration of vesting as
may
be provided in the participants’ written agreement. The
2015
Plan expires in
December
2025.
 
Non-Plan Stock Options
 
Periodically, the Company has granted options outside of the
1999,
2004
and
2015
Plans to various employees and consultants. In the event of change in control, as defined, certain of the non-plan options outstanding vest immediately.
  
Stock Option Activity
 
Information summarizing option activity is as follows:
 
 
 
 
Number of Options
 
 
Weighted
average
exercise
 
 
Weighted
average
remaining
life
 
 
Aggregate
intrinsic
 
 
 
1999 Plan
 
 
2004 Plan
 
 
2015
Plan
 
 
Non Plan
 
 
Total
 
 
price
 
 
(in years)
 
 
value
 
                                                                 
Outstanding, as of December 31, 2014
   
20,834
     
136,276
     
     
184,167
     
341,277
    $
4.32
     
 
     
 
 
                                                                 
Granted
   
     
     
     
119,000
     
119,000
     
2.16
     
 
     
 
 
Exercised
   
     
     
     
     
     
 
     
 
     
 
 
Forfeited
   
     
(3,473
)
   
     
(38,531
)
   
(42,004
)
   
3.72
     
 
     
 
 
Expired
   
     
(47,795
)
   
     
(5,548
)
   
(53,343
)
   
3.00
     
 
     
 
 
Outstanding, as of December 31, 2015
 
 
20,834
 
 
 
85,008
 
 
 
 
 
 
259,088
 
 
 
364,930
 
 
$
3.87
 
 
 
4.57
 
 
$
240
 
                                                                 
Granted
   
     
     
27,087
     
     
27,087
     
2.74
     
 
     
 
 
Exercised
   
     
     
     
     
     
 
     
 
     
 
 
Forfeited
   
     
     
(2,084
)
   
(8,335
)
   
(10,419
)
   
2.16
     
 
     
 
 
Expired
   
(20,834
)
   
(15,628
)
   
     
(3,473
)
   
(39,935
)
   
2.50
     
 
     
 
 
Outstanding, as of December 31, 2016
   
 
 
 
69,380
 
 
 
25,003
 
 
 
247,280
 
 
 
341,663
 
 
$
3.99
 
 
 
4.23
 
 
$
53,936
 
Vested or expected to vest
at
December 31, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
307,164
 
 
$
4.16
 
 
 
4.04
 
 
$
41,816
 
Exercisable at December 31, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
216,566
 
 
$
4.56
 
 
 
3.51
 
 
$
17,367
 
 
The options outstanding and exercisable at
December
 
31,
2016
were in the following exercise price ranges:
 
 
   
 
 
 
Options Outstanding
 
 
Options Exercisable
 
Range of exercise prices
 
 
Number of
shares
 
 
Weighted
average
exercise
price
 
 
Weighted
average
remaining
life (in years)
 
 
Number
exercisable
 
 
Weighted
average
exercise
price
 
$ 1.90
-
3.00
     
122,485
    $
2.24
     
5.81
     
34,815
    $
2.15
 
  3.01
-
5.00
     
197,927
     
4.47
     
3.66
     
160,500
     
4.41
 
  5.01
-
11.04
     
21,251
     
9.67
     
0.72
     
21,251
     
9.67
 
$ 1.90
-
11.04
     
341,663
     
 
     
 
     
216,566
     
 
 
 
The aggregate intrinsic value in the table above represents the total intrinsic value, based on the Company’s closing stock price of
$2.65
as of
December
 
31,
2016,
which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options exercisable as of
December
 
31,
2016
was
34,815.
   
The weighted average fair value of options granted during the years ended
December
 
31,
2016
and
2015
was
$1.86
and
$1.68
per share, respectively. The total intrinsic value of options exercised during the years ended
December
 
31,
2016
and
2015
was
$0
and
$0,
respectively. The total fair value of shares vested during the years ended
December
 
31,
2016
and
2015
was
$285,430
and
$265,247
respectively.
 
As of
December
 
31,
2016,
future compensation cost related to nonvested stock options is
$166,146
and will be recognized over an estimated weighted average period of
1.18
years.